Roche agrees $1bn deal with Dualitas for bispecific antibody research

The collaboration will leverage Dualitas’ proximity biology capabilities to produce bispecific antibody therapeutics. Credit: THICHA SATAPITANON / Shutterstock.com.



  • Roche Dualitas Therapeutics